Remodeling of the fibrillation pathway of α-synuclein by interaction with antimicrobial peptide LL-III
dc.contributor.author | Oliva, Rosario | |
dc.contributor.author | Mukherjee, Sanjib K. | |
dc.contributor.author | Ostermeier, Lena | |
dc.contributor.author | Pazurek, Lilli A. | |
dc.contributor.author | Kriegler, Simon | |
dc.contributor.author | Bader, Verian | |
dc.contributor.author | Prumbaum, Daniel | |
dc.contributor.author | Raunser, Stefan | |
dc.contributor.author | Winklhofer, Konstanze F. | |
dc.contributor.author | Tatzelt, Jörg | |
dc.contributor.author | Winter, Roland | |
dc.date.accessioned | 2022-03-23T14:04:19Z | |
dc.date.available | 2022-03-23T14:04:19Z | |
dc.date.issued | 2021-06-24 | |
dc.description.abstract | Liquid-liquid phase separation (LLPS) has emerged as a key mechanism for intracellular organization, and many recent studies have provided important insights into the role of LLPS in cell biology. There is also evidence that LLPS is associated with a variety of medical conditions, including neurodegenerative disorders. Pathological aggregation of α-synuclein, which is causally linked to Parkinson's disease, can proceed via droplet condensation, which then gradually transitions to the amyloid state. We show that the antimicrobial peptide LL-III is able to interact with both monomers and condensates of α-synuclein, leading to stabilization of the droplet and preventing conversion to the fibrillar state. The anti-aggregation activity of LL-III was also confirmed in a cellular model. We anticipate that studying the interaction of antimicrobial-type peptides with liquid condensates such as α-synuclein will contribute to the understanding of disease mechanisms (that arise in such condensates) and may also open up exciting new avenues for intervention. | en |
dc.identifier.uri | http://hdl.handle.net/2003/40820 | |
dc.identifier.uri | http://dx.doi.org/10.17877/DE290R-22677 | |
dc.language.iso | en | de |
dc.relation.ispartofseries | Chemistry - a European journal;27(46) | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
dc.subject | α-synuclein | en |
dc.subject | Antimicrobial peptide | en |
dc.subject | Lewy bodies | en |
dc.subject | Liquid-liquid phase separation | en |
dc.subject | LL-III | en |
dc.subject | Protein condensate | en |
dc.subject.ddc | 540 | |
dc.title | Remodeling of the fibrillation pathway of α-synuclein by interaction with antimicrobial peptide LL-III | en |
dc.type | Text | de |
dc.type.publicationtype | article | de |
dcterms.accessRights | open access | |
eldorado.secondarypublication | true | de |
eldorado.secondarypublication.primarycitation | R. Oliva, S. K. Mukherjee, L. Ostermeier, L. A. Pazurek, S. Kriegler, V. Bader, D. Prumbaum, S. Raunser, K. F. Winklhofer, J. Tatzelt, R. Winter, Chem. Eur. J. 2021, 27, 11845. | de |
eldorado.secondarypublication.primaryidentifier | https://doi.org/10.1002/chem.202101592 | de |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Chemistry A European J - 2021 - Oliva - Remodeling of the Fibrillation Pathway of ‐Synuclein by Interaction with.pdf
- Size:
- 3.22 MB
- Format:
- Adobe Portable Document Format
- Description:
- DNB
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 4.85 KB
- Format:
- Item-specific license agreed upon to submission
- Description: